Johnson Investment Counsel’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,480
Closed -$199K 796
2024
Q1
$199K Buy
+13,480
New +$199K ﹤0.01% 729